市場調查報告書
商品編碼
1578764
越南人用疫苗進口量:2024-2033年Vietnam Human Vaccines Import Research Report 2024-2033 |
人類疫苗多年來一直具有保護作用,在人類健康中發揮重要作用。在現代生活中,疫苗接種已成為預防某些疾病特別是流行病和傳染病的最有效方法,並廣泛接受。
到2023年底,越南總人口將突破1億,淨人口每年增加超過100萬人。隨著經濟發展和資本收入增加,越南製藥業成長強勁。此外,越南政府持續實施扶持政策,擴大醫療支出。根據CRI報道,越南自由貿易協定消除了外國製藥企業的市場准入壁壘,對來自歐洲和部分地區的藥品進口關稅非常低,甚至沒有。越南製藥業高度依賴進口藥品。
疫苗可以預防某些疾病、減少疾病傳播並改善公眾健康。 CRI分析表示,越南對人用疫苗的需求穩步成長。但由於國內產能有限,越南人用疫苗市場主要依賴進口產品。近年來,越南進口了大量疫苗,包括COVID-19疫苗、流感疫苗、HPV疫苗以及四價和六價兒科疫苗。越南對疫苗的需求很高,進口人用疫苗的數量不斷增加,特別是在COVID-19之後,因為政府和人民都更加重視健康。
疫苗產業有原料供應(抗原、佐劑等)及製造業(研究、製造、品質管制等)等上游環節,以及經銷及免疫服務等下游環節。疫苗生產需要嚴格的衛生條件、先進的製造設備和技術以及高標準的品質控制。全球主要疫苗生產和出口企業都是研發能力較強的大型生物製藥公司,如Pfizer、Moderna、AstraZeneca等,而目前越南國內企業只能生產有限種類的疫苗。
在 COVID-19 期間,越南進口了大量疫苗以滿足緊急需求。根據CRI表示,越南人用疫苗生產的基礎設施和技術落後,使其高度依賴國際市場供應。此外,越南政府高度重視公共衛生,並透過涵蓋常見傳染病的國家免疫計劃(NIP)促進提高疫苗接種覆蓋率。越南已與多家國際疫苗供應商簽署合作協議,確保疫苗穩定供應。
根據CRI資料,2023年越南人用疫苗進口總額達4.7億美元。此外,2024年1月至5月,越南疫苗進口總額超過2.5億美元,比上年增加30%以上。預計這一趨勢在未來幾年將繼續以穩定的速度成長。
整體而言,由於越南人口成長、經濟水準提高以及健康意識的提高,越南人用疫苗市場規模預計將擴大。根據CRI分析,由於越南國產人用疫苗產能和技術水準相對較低,未來幾年越南人用疫苗進口預計將持續成長。
本報告調查了越南人用疫苗進口趨勢,包括國家概況、進口額、進口量、進口價格等趨勢和預測,主要進口國和主要買家的詳細分析,並進行了總結木製家具出口供應商及主要影響因素分析
免責聲明
服務保障
Human vaccines offer longstanding protection, playing an indispensable role in human health. In modern life, vaccination has become the most effective way to prevent from specific diseases, especially pestilences and infection, widely accepted by people.
By the end of 2023, Vietnam's total population has surpassed 100 million, with a net population growth of more than 1 million annually. As the economy progressing and capital income increasing, the pharmaceutical industry in Vietnam is growing vigorously. Also, the Vietnam government continues to issue support policies and expand healthcare spending. For example, the national strategy for pharmaceutical industry development through 2030, with a vision to 2045 approved in 2023 set out clear development targets for specific industry including vaccines. According to CRI, Vietnam's free trade agreements have removed market access barriers for foreign companies in its pharmaceutical industry, and import tariffs on medicines from Europe and some regions are very low or even non-existent. Vietnam's pharmaceutical industry is highly dependent on imported pharmaceutical products.
Vaccines can prevent certain diseases, reduce the spread of illness, and improve public health. CRI has analyzed that the demand for human vaccines in Vietnam is steadily increasing. However, due to limited domestic production capacity, Vietnam's human vaccine market mainly relies on imported products. In recent years, Vietnam has imported a large number of vaccines, including COVID-19 vaccines, influenza vaccines, HPV vaccines, and quadrivalent and hexavalent pediatric vaccines. The demand for vaccines in Vietnam is high, especially in the post-COVID-19 era, as both the government and the public place greater emphasis on health, leading to an increase in the number of imported human vaccines.
The vaccine industry involves upstream sectors such as raw material supply (e.g., antigens, adjuvants), manufacturing (including research, production, and quality control), and downstream sectors like distribution and vaccination services. Vaccine production requires strict hygiene conditions, advanced production equipment and technology, and high standards of quality control. Leading global vaccine producers and exporters are typically large biopharmaceutical companies with strong R&D capabilities, such as Pfizer, Moderna, and AstraZeneca. Currently, Vietnamese domestic companies are only able to produce a limited variety of vaccines.
During the COVID-19 pandemic, Vietnam imported a significant number of vaccines to meet the urgent demand. According to CRI, because of the underdeveloped infrastructure and technology for human vaccine production in Vietnam, the country is heavily reliant on the international market for supply. Moreover, the Vietnamese government is highly committed to public health, promoting higher vaccination rates through the National Immunization Program (NIP), which covers a range of common infectious diseases. Vietnam has entered into cooperation agreements with various international vaccine suppliers to ensure a stable supply of vaccines.
Based on data from CRI, in 2023, Vietnam's total imports of human vaccines reached USD 470 million. From January to May 2024, Vietnam's total vaccine imports exceeded USD 250 million, representing a year-on-year growth of over 30%. This trend is expected to continue at a steady growth rate in the coming years.
CRI's analysis reveals that from 2021 to 2024, Vietnam's primary sources of human vaccine imports were the United States, France, and Belgium. Major companies exporting human vaccines to Vietnam include GlaxoSmithKline Biologicals S.A., Merck Sharp & Dohme (Asia) Ltd., and Sanofi Pasteur.
The main importers of human vaccines in Vietnam are pharmaceutical companies, distributors, and logistics providers, mostly foreign enterprises, such as GSK Pharma Vietnam Company, MSD HH Vietnam Ltd., and Sanofi-Aventis Vietnam Company.
Overall, with Vietnam's growing population and rising economic level, coupled with increased awareness of health, the size of Vietnam's human vaccine market is set to expand. CRI's analysis indicates that due to the relatively low production capacity and technological levels of domestic human vaccines, Vietnam's human vaccine imports are expected to continue growing in the coming years.
Topics covered:
The Import and Export of Human Vaccines in Vietnam (2021-2024)
Total Import Volume and Percentage Change of Human Vaccines in Vietnam (2021-2024)
Total Import Value and Percentage Change of Human Vaccines in Vietnam (2021-2024)
Total Import Volume and Percentage Change of Human Vaccines in Vietnam (2024)
Total Import Value and Percentage Change of Human Vaccines in Vietnam (2024)
Average Import Price of Human Vaccines in Vietnam (2021-2024)
Top 10 Sources of Human Vaccines Imports in Vietnam and Their Supply Volume
Top 10 Suppliers in the Import Market of Human Vaccines in Vietnam and Their Supply Volume
Top 10 Importers of Human Vaccines in Vietnam and Their Import Volume
How to Find Distributors and End Users of Human Vaccines in Vietnam
How Foreign Enterprises Enter the Human Vaccines Market of Vietnam
Forecast for the Import of Human Vaccines in Vietnam (2024-2033)
Disclaimer
Service Guarantees